+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Psoriasis Treatment Market - Global Forecast 2026-2032- Product Image
Psoriasis Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Psoriasis Treatment Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090282
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Psoriasis Treatment Market is projected to reach USD 23.01 Billion in 2026. It is expected to continue growing at a CAGR of 9.00%, reaching USD 38.76 Billion by 2032.

Psoriasis Treatment: Executive Summary

Psoriasis treatment is evolving toward individualized, long-term disease control across topical, phototherapy, conventional systemic, biologic, and targeted oral approaches. Clinical decision-making increasingly considers disease severity, affected body sites, psoriatic arthritis, comorbidities, prior treatment response, safety, administration preferences, and access to specialist care. Treatment goals commonly extend beyond visible lesion improvement to durable skin clearance, symptom relief, functional recovery, and quality-of-life gains.

Treatment Is Shifting Toward Earlier, More Individualized Control

The treatment landscape is being reshaped by precision in patient selection, expanded systemic options, and stronger emphasis on shared decision-making. Biologic and targeted therapies have broadened the ability to address moderate-to-severe disease, while topical combinations and nonbiologic systemic agents remain important for localized or resource-sensitive care. Biosimilar adoption, safety monitoring, treatment sequencing, adherence support, and recognition of psoriatic arthritis and cardiometabolic comorbidities are also influencing clinical pathways.

Artificial Intelligence Is Strengthening Diagnosis, Monitoring, and Care Delivery

Artificial intelligence can support psoriasis care by improving image-assisted assessment, lesion documentation, severity scoring, treatment-response tracking, and identification of patients who may require specialist evaluation. Machine-learning tools may also help integrate clinical histories, comorbidities, laboratory results, and patient-reported outcomes into treatment decisions. However, implementation requires representative validation, transparent performance standards, privacy safeguards, clinician oversight, and careful management of bias, particularly where skin-tone diversity and uneven access to digital infrastructure affect model reliability.

Regional Patterns Reflect Uneven Access and Different Care Priorities

North America generally combines broad access to advanced systemic therapies with sophisticated specialty care, although affordability and insurance restrictions can influence treatment continuity. Europe emphasizes guideline-based management, health-technology assessment, biosimilar use, and coordinated care across diverse national systems. Asia-Pacific contains highly varied clinical capacity, reimbursement environments, and disease-recognition patterns, creating demand for scalable treatment pathways. Latin America continues to balance specialist access and affordability with growing interest in modern systemic care. The Middle East is seeing greater attention to chronic inflammatory disease management, while access and diagnostic capacity differ substantially across countries. Africa faces pronounced disparities in dermatology services, medicine availability, and continuity of care, underscoring the importance of practical, affordable treatment models.

Economic and Political Groupings Shape Access, Standards, and Collaboration

ASEAN markets present varied regulatory systems, healthcare capacity, and reimbursement arrangements, making regional coordination valuable for diagnosis and treatment access. BRICS members span substantial differences in disease burden, pharmaceutical manufacturing, specialist availability, and public-sector delivery, with affordability and local production remaining important considerations. The European Union supports cross-border scientific and regulatory collaboration while retaining national differences in reimbursement and implementation. G7 countries generally have strong research and specialty-care infrastructures but continue to address affordability, treatment inequities, and service capacity. GCC health systems often combine advanced urban care with a need for broader chronic-disease integration. NATO members encompass diverse health systems, but collaboration in digital health, supply resilience, and clinical preparedness can support continuity of care.

Country-Level Priorities Range from Innovation Access to Basic Service Capacity

Australia combines established dermatology services with attention to rural access and long-term disease management. Brazil must address geographic inequality, public-system capacity, and access to systemic therapies. Canada faces regional variation in specialist availability and reimbursement pathways. China is expanding dermatology capacity and treatment options while managing differences between urban and less-served areas. France, Germany, Italy, and Spain operate within mature European care environments, with national variation in reimbursement, prescribing, and biologic or biosimilar uptake. India continues to navigate a large and diverse patient population, uneven specialist access, and affordability constraints. Japan emphasizes careful clinical management within an aging population and a structured healthcare system. Mexico faces differences in access between metropolitan and underserved communities. Russia’s treatment environment is influenced by healthcare-system variation and supply considerations. South Korea combines advanced medical infrastructure with demand for efficient, patient-centered specialty care. The United Kingdom continues to emphasize guideline-led dermatology, referral pathways, and service-capacity management. The United States offers extensive therapeutic choice but must address cost, coverage restrictions, and disparities in specialist access.

Industry Leaders Should Prioritize Access, Evidence, and Integrated Care

Leaders should design portfolios and services around distinct patient segments rather than treatment class alone, pairing clinical efficacy with safety, convenience, persistence, and affordability. Evidence generation should include patient-reported outcomes, difficult-to-treat sites, diverse skin tones, psoriatic arthritis, and real-world treatment sequencing. Organizations can improve outcomes by supporting earlier referral, adherence education, comorbidity screening, nurse-led monitoring, and coordination between dermatology, rheumatology, primary care, and mental-health services. Digital and AI capabilities should be introduced with clinical validation, explainability, privacy protection, and human review. Regional strategies should account for local reimbursement, supply reliability, regulatory requirements, and workforce capacity rather than assuming a single global access model.

Research Methodology for a Reliable Psoriasis Treatment Assessment

A robust assessment should combine systematic review of peer-reviewed clinical evidence, treatment guidelines, regulatory documents, public-health sources, reimbursement policies, and healthcare-access data. Findings should be triangulated across therapeutic classes, disease severity, treatment settings, patient characteristics, and geographic contexts. Qualitative inputs from clinicians, pharmacists, payers, and patients can clarify implementation barriers and treatment preferences. Evidence quality should be assessed for consistency, external validity, transparency, and recency, with explicit separation of established findings from emerging technologies and unresolved questions. The analysis should avoid unsupported estimates and should document limitations related to heterogeneous endpoints, variable diagnostic practices, and incomplete real-world data.

Conclusion: Better Psoriasis Care Depends on Personalization and Equitable Delivery

Psoriasis treatment is progressing toward more targeted, durable, and patient-centered management, but therapeutic innovation alone will not ensure better outcomes. The next phase of care depends on accurate diagnosis, timely escalation, sustained adherence, comorbidity management, reliable access, and coordination across specialties and health systems. Regional and country differences make adaptable implementation essential. Organizations that combine rigorous evidence, responsible digital innovation, affordability strategies, and inclusive care pathways will be best positioned to improve long-term outcomes for people living with psoriasis.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Psoriasis Treatment Market, by Drug Type
7.1. Introduction
7.2. Systemic Treatments
7.2.1. Biologics
7.2.1.1. IL-17 Inhibitors
7.2.1.2. IL-23 Inhibitors
7.2.1.3. T-cell Inhibitors
7.2.1.4. TNF-alpha Inhibitors
7.2.2. Oral Medications
7.2.3. Phototherapy
7.3. Topical Treatments
7.3.1. Calcineurin Inhibitors
7.3.2. Corticosteroids
7.3.3. Retinoids
7.3.4. Vitamin D Analogues
8. Psoriasis Treatment Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Oral
8.4. Topical
9. Psoriasis Treatment Market, by Disease Type
9.1. Introduction
9.2. Erythrodermic Psoriasis
9.3. Guttate Psoriasis
9.4. Inverse Psoriasis
9.5. Plaque Psoriasis
9.6. Pustular Psoriasis
10. Psoriasis Treatment Market, by End-User
10.1. Introduction
10.2. Ambulatory Surgical Centers (ASCs)
10.3. Homecare Settings
10.4. Hospitals
10.5. Specialty Clinics
11. Psoriasis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.3. Online
12. Psoriasis Treatment Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Psoriasis Treatment Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Psoriasis Treatment Market, by Country
14.1. Introduction
14.2. United States
14.3. Germany
14.4. China
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. Russia
14.9. Brazil
14.10. Canada
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Almirall, S.A.
16.3. Amgen Inc.
16.4. Bausch Health Companies Inc.
16.5. Biogen Inc.
16.6. Boehringer Ingelheim GmbH
16.7. Bristol-Myers Squibb Company
16.8. Celltrion, Inc.
16.9. Eli Lilly and Company
16.10. Fresenius Kabi AG
16.11. GlaxoSmithKline plc
16.12. Johnson & Johnson Services, Inc.
16.13. LEO Pharma A/S
16.14. Lupin Limited
16.15. Merck & Co., Inc.
16.16. Mitsubishi Tanabe Pharma Corporation
16.17. Novartis AG
16.18. Pfizer Inc.
16.19. Samsung Bioepis Co., Ltd.
16.20. Sanofi S.A.
16.21. Sun Pharmaceutical Industries Ltd.
16.22. Takeda Pharmaceutical Company Limited
16.23. UCB S.A.
16.24. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Psoriasis Treatment Market, Years Considered for the Study
FIGURE 2. Global Psoriasis Treatment Market, Research Design
FIGURE 3. Global Psoriasis Treatment Market, Research Framework
FIGURE 4. Global Psoriasis Treatment Market, Data Triangulation
FIGURE 5. Global Psoriasis Treatment Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Psoriasis Treatment Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 7. Global Psoriasis Treatment Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Psoriasis Treatment Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Psoriasis Treatment Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Psoriasis Treatment Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 11. Global Psoriasis Treatment Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Psoriasis Treatment Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Psoriasis Treatment Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Psoriasis Treatment Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Psoriasis Treatment Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Psoriasis Treatment Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Psoriasis Treatment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Psoriasis Treatment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Psoriasis Treatment Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Psoriasis Treatment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Psoriasis Treatment Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Psoriasis Treatment Market Segmentation & Coverage
TABLE 2. Global Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 3. Global Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 4. Global Systemic Treatments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Systemic Treatments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Systemic Treatments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global IL-17 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global IL-17 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global IL-17 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global IL-23 Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global IL-23 Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global IL-23 Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global T-cell Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global T-cell Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global T-cell Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global TNF-alpha Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global TNF-alpha Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global TNF-alpha Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Oral Medications Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Phototherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Phototherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Phototherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Topical Treatments Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Topical Treatments Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Topical Treatments Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Calcineurin Inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Calcineurin Inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Calcineurin Inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Retinoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Retinoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Retinoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Vitamin D Analogues Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Vitamin D Analogues Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Vitamin D Analogues Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 44. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 54. Global Erythrodermic Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Erythrodermic Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Erythrodermic Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Guttate Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Guttate Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Guttate Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Inverse Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Inverse Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Inverse Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Plaque Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Plaque Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Plaque Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pustular Psoriasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pustular Psoriasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pustular Psoriasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 70. Global Ambulatory Surgical Centers (ASCs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Ambulatory Surgical Centers (ASCs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Ambulatory Surgical Centers (ASCs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 106. North America Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. North America Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 108. North America Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 109. North America Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 110. North America Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 111. North America Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 112. North America Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 113. North America Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 114. North America Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. North America Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 116. Latin America Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Latin America Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 118. Latin America Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 119. Latin America Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 120. Latin America Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 121. Latin America Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 122. Latin America Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 123. Latin America Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 124. Latin America Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. Latin America Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 126. Europe Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Europe Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 128. Europe Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 129. Europe Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 130. Europe Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 131. Europe Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 132. Europe Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 133. Europe Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 134. Europe Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 135. Europe Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 136. Middle East Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Middle East Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 138. Middle East Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 139. Middle East Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 140. Middle East Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 141. Middle East Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 142. Middle East Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 143. Middle East Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 144. Middle East Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. Middle East Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 146. Africa Psoriasis Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Africa Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 148. Africa Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 149. Africa Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 150. Africa Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 151. Africa Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 152. Africa Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 153. Africa Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 154. Africa Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 155. Africa Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 156. Global Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. ASEAN Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. ASEAN Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 159. ASEAN Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 160. ASEAN Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 161. ASEAN Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 162. ASEAN Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 163. ASEAN Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 164. ASEAN Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 165. ASEAN Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 166. ASEAN Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 167. GCC Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. GCC Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 169. GCC Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 170. GCC Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 171. GCC Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 172. GCC Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 173. GCC Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 174. GCC Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 175. GCC Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. GCC Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 177. European Union Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. European Union Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 179. European Union Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 180. European Union Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 181. European Union Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 182. European Union Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 183. European Union Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 184. European Union Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 185. European Union Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. European Union Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 187. BRICS Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. BRICS Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 189. BRICS Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 190. BRICS Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 191. BRICS Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 192. BRICS Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 193. BRICS Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 194. BRICS Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 195. BRICS Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. BRICS Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 197. G7 Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. G7 Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 199. G7 Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 200. G7 Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 201. G7 Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 202. G7 Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 203. G7 Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 204. G7 Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 205. G7 Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. G7 Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 207. NATO Psoriasis Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. NATO Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 209. NATO Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 210. NATO Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 211. NATO Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 212. NATO Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 213. NATO Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 214. NATO Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 215. NATO Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. NATO Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 217. Global Psoriasis Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. United States Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 219. United States Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 220. United States Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 221. United States Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 222. United States Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 223. United States Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 224. United States Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 225. United States Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 226. United States Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 227. United States Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 228. Germany Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 229. Germany Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 230. Germany Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 231. Germany Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 232. Germany Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 233. Germany Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 234. Germany Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 235. Germany Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 236. Germany Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Germany Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 238. China Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 239. China Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 240. China Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 241. China Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 242. China Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 243. China Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 244. China Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 245. China Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 246. China Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. China Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 248. United Kingdom Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 249. United Kingdom Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 250. United Kingdom Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 251. United Kingdom Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 252. United Kingdom Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 253. United Kingdom Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 254. United Kingdom Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 255. United Kingdom Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 256. United Kingdom Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. United Kingdom Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 258. India Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 259. India Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 260. India Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 261. India Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 262. India Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 263. India Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 264. India Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 265. India Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 266. India Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 267. India Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 268. Japan Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 269. Japan Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 270. Japan Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 271. Japan Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 272. Japan Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 273. Japan Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 274. Japan Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 275. Japan Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 276. Japan Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. Japan Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 278. Russia Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 279. Russia Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 280. Russia Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 281. Russia Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 282. Russia Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 283. Russia Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 284. Russia Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 285. Russia Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 286. Russia Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. Russia Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 288. Brazil Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 289. Brazil Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 290. Brazil Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 291. Brazil Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 292. Brazil Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 293. Brazil Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 294. Brazil Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 295. Brazil Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 296. Brazil Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. Brazil Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 298. Canada Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 299. Canada Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 300. Canada Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 301. Canada Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 302. Canada Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 303. Canada Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 304. Canada Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 305. Canada Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 306. Canada Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 307. Canada Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 308. Italy Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 309. Italy Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 310. Italy Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 311. Italy Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 312. Italy Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 313. Italy Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 314. Italy Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 315. Italy Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 316. Italy Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. Italy Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 318. Mexico Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 319. Mexico Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 320. Mexico Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 321. Mexico Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 322. Mexico Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 323. Mexico Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 324. Mexico Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 325. Mexico Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 326. Mexico Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 327. Mexico Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 328. France Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 329. France Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 330. France Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 331. France Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 332. France Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 333. France Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 334. France Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 335. France Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 336. France Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 337. France Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 338. Spain Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 339. Spain Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 340. Spain Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 341. Spain Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 342. Spain Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 343. Spain Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 344. Spain Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 345. Spain Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 346. Spain Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. Spain Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 348. Australia Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 349. Australia Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 350. Australia Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 351. Australia Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 352. Australia Psoriasis Treatment Market Size, by Topical Treatments, 2017-2032 (USD Million)
TABLE 353. Australia Psoriasis Treatment Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 354. Australia Psoriasis Treatment Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 355. Australia Psoriasis Treatment Market Size, by End-User, 2017-2032 (USD Million)
TABLE 356. Australia Psoriasis Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 357. Australia Psoriasis Treatment Market Size, by Offline, 2017-2032 (USD Million)
TABLE 358. South Korea Psoriasis Treatment Market Size, 2017-2032 (USD Million)
TABLE 359. South Korea Psoriasis Treatment Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 360. South Korea Psoriasis Treatment Market Size, by Systemic Treatments, 2017-2032 (USD Million)
TABLE 361. South Korea Psoriasis Treatment Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 362. South Korea Psoriasis Treatment Market Size

Companies Mentioned

  • AbbVie Inc.
  • Almirall, S.A.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Celltrion, Inc.
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Pfizer Inc.
  • Samsung Bioepis Co., Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • UCB S.A.
  • Viatris Inc.

Related Topics

Related Reports

Psoriasis Market Report 2026 - Product Image

Psoriasis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Psoriasis Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Psoriasis Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Global Psoriasis Treatment Market Outlook, 2031 - Product Image

Global Psoriasis Treatment Market Outlook, 2031

  • Report
  • 209 Pages
  • Global
From
Chronic Plaque Psoriasis Market Report 2026 - Product Image

Chronic Plaque Psoriasis Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Psoriasis Treatment - Global Strategic Business Report - Product Image

Psoriasis Treatment - Global Strategic Business Report

  • Report
  • 566 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.